| Beta-blockers and spironolactone in heart failure. | |
| | |
MedLine Citation:
|
PMID: 10980877 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Neurohormonal antagonism is now recognized as an essential treatment modality for heart failure. As a prime example, the benefits of blocking the renin-angiotensin system with angiotensin converting enzyme inhibitors are clearly established for all four New York Heart Association classes. In this clinical trials review, we discuss two other therapies with neurohormonal targets: beta-blockers and the sympathetic nervous system, and the aldosterone antagonist spironolactone. |
| | |
Authors:
|
M L Kukin |
Related Documents
:
|
6874387 - Factitious hypertension with mineralocorticoid excess in an infant. 1781767 - Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and ... 2988827 - Blood pressure responses to acth and adrenaline infusions in dogs. 18284637 - Clinical and biochemical characteristics of normotensive patients with primary aldoster... 21215947 - Feline systemic hypertension: diagnosis and management. 8519717 - Wrapping of the legs reduces the decrease in blood pressure following spinal anesthesia... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current cardiology reports Volume: 2 ISSN: 1523-3782 ISO Abbreviation: Curr Cardiol Rep Publication Date: 2000 Mar |
Date Detail:
|
Created Date: 2000-11-21 Completed Date: 2000-11-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100888969 Medline TA: Curr Cardiol Rep Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 87-9 Citation Subset: IM |
Affiliation:
|
Director, Heart Failure Program, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Aldosterone Antagonists / therapeutic use* Carbazoles / therapeutic use Heart Failure / drug therapy* Humans Metoprolol / therapeutic use Propanolamines / therapeutic use Randomized Controlled Trials as Topic Spironolactone / therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Aldosterone Antagonists; 0/Carbazoles; 0/Propanolamines; 37350-58-6/Metoprolol; 52-01-7/Spironolactone; 72956-09-3/carvedilol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anticoagulant therapy in special circumstances.
Next Document: Surgical approaches to dilated cardiomyopathy.